Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Baseline/Control Phase”

Showing 8 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05621616
What this trial is testing

Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Global Development, Inc. 7
Early research (Phase 1)Study completedNCT03997760
What this trial is testing

SHP655 (rADAMTS13) in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Shire 19
Large-scale testing (Phase 3)Study completedNCT00359112
What this trial is testing

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

Who this might be right for
Non-Insulin-Dependent Diabetes Mellitus
GlaxoSmithKline 544
Testing effectiveness (Phase 2)Ended earlyNCT04040049
What this trial is testing

A Fabry Disease Gene Therapy Study

Who this might be right for
Fabry DiseaseLysosomal Storage Diseases
Spur Therapeutics 3
Large-scale testing (Phase 3)Active Not RecruitingNCT05271409
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Who this might be right for
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Hoffmann-La Roche 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT06653842
What this trial is testing

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations

Who this might be right for
Cutaneous Venous Malformations
Palvella Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01423188
What this trial is testing

The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation

Who this might be right for
Coronary Artery DiseaseDyslipidemia
Resverlogix Corp 176
Testing effectiveness (Phase 2)Study completedNCT02686788
What this trial is testing

TMP001 in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Remitting-Relapsing Multiple Sclerosis
Dr. Frank Behrens 9

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation